Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Nihon Chouzai Co ( (JP:3341) ).
Nihon Chouzai Co., Ltd. reported a significant increase in its financial performance for the first half of the fiscal year ending March 31, 2026, with net sales rising by 9.1% and operating profit surging by 887.4% compared to the previous year. However, the company is scheduled to be delisted from the Tokyo Stock Exchange on December 19, 2025, following a series of corporate restructuring procedures, which will impact its future financial disclosures and market presence.
The most recent analyst rating on (JP:3341) stock is a Hold with a Yen3834.00 price target. To see the full list of analyst forecasts on Nihon Chouzai Co stock, see the JP:3341 Stock Forecast page.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily involved in the pharmaceutical industry. It focuses on providing pharmaceutical services and products, with a market emphasis on healthcare solutions.
Average Trading Volume: 171,137
Technical Sentiment Signal: Buy
Current Market Cap: Yen113.2B
See more data about 3341 stock on TipRanks’ Stock Analysis page.